Articles From: Celestica Completes a Program Share Repurchase to Cellcom israel Announces Hearing Regarding Call Center Services


2014/7/22
Celestica Completes a Program Share Repurchase Canada NewsWire TORONTO , July 22, 2014 /CNW/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced that it completed a program share repurchase (a PSR) under its Normal Course Issuer Bid.
Sign-up for Celestica Completes a Program Share Repurchase investment picks
2014/7/2
State-of-the-art facility accelerates prototyping and commercialization of miniaturized electronics products TORONTO , July 2, 2014 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced the opening of its new microelectronics laboratory at its headquarters in Toronto, Ontario in Canada .
Sign-up for Celestica Opens Microelectronics Laboratory to Bring Products to Market investment picks
2014/7/30
Honorees receive award during CIO 100 Symposium & Awards Ceremony TORONTO , July 30, 2014 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions today announced it was named to the 2014 CIO 100, which is developed by IDG's CIO Magazine.
Sign-up for Celestica recognized by CIO Magazine as one of its CIO 100 Award winners investment picks
ON Semiconductor (Nasdaq: ONNN ) has been recognized as an honouree in the 2013 Total Cost of Ownership (TCOO TM ) Supplier Award program from Celestica, a global leader in the delivery of end-to-end product lifecycle solutions.
Sign-up for Celestica Recognizes ON Semiconductor as an Honouree in its 2013 Total Cost of Ownership Supplier Awards Program investment picks
PMC-Sierra, Inc. (PMC®) (Nasdaq:PMCS), the semiconductor and software solutions innovator transforming networks that connect, move and store big data, has been recognized as an honouree in the 2013 Total Cost of Ownership (TCOO TM ) Supplier Award program from Celestica, a global leader in the delivery of end-to-end product lifecycle solutions.
Sign-up for Celestica Recognizes PMC as 2013 TCOO Supplier Awards Program Honoree investment picks
Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, July 24, 2014 at 9 a.m. ET to discuss second quarter 2014 financial and operational results.
Sign-up for Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014 investment picks
Celgene Corporation (NASDAQ:CELG) announced that Celgene management will provide an overview of the Company at two upcoming investor conferences in the month of September.
Sign-up for Celgene Corporation to Present at Investor Conferences in September investment picks
Celgene Corporation (NASDAQ:CELG) today announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in patients with active ankylosing spondylitis.
Sign-up for Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis investment picks
Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,845 million for the second quarter of 2014, an 18 percent increase from the same period in 2013.
Sign-up for Celgene Reports Second Quarter 2014 Operating and Financial Results investment picks
NEW YORK (MarketWatch) -- Celgene Corp.
Sign-up for Celgene shareholders approve 2-for-1 stock split investment picks
NEW YORK (MarketWatch) -- Celgene Corp.
Sign-up for Celgene shares slump as late-stage trial misses goal investment picks
Celgene Corp.
Sign-up for Celgene shares up on news of positive late-stage drug trial investment picks
Celgene Corporation (NASDAQ:CELG) today announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares of the Company's common stock at the Company’s Annual Meeting of Stockholders on June 18, 2014.
Sign-up for Celgene Stockholders Approve Two-for-One Stock Split investment picks
2014/8/28
World Assurance Group, Inc. ( www.worldassurancegroup.com ) (OTC Pink:WDAS) today announces that it will be exhibiting at ad:tech London where it will launch its AdKoin app and advertising platform.
Sign-up for CellAd Seeks Its Share of $18 Billion Mobile Advertising Market with the Launch of Its Advertising Platform and AdKoin App at ad:tech London investment picks
SAN DIEGO, Aug.
Sign-up for Celladon Announces Commencement of Public Offering of Common Stock investment picks
SAN DIEGO, Aug.
Sign-up for Celladon Announces Pricing of Public Offering of Common Stock investment picks
SAN DIEGO, July 21, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation today announced an exclusive, global license from Enterprise Partners Venture Capital for gene therapy applications of the membrane-bound form of the Stem Cell Factor gene (mSCF) for treatment of cardiac ischemia.
Sign-up for Celladon Corporation Announces In-License of Stem Cell Factor Development Program investment picks
SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced it has launched two new clinical development initiatives for MYDICAR®, its lead product candidate, in patients with end-stage renal disease (ESRD) undergoing surgery for arteriovenous fistula (AVF) creation in preparation for hemodialysis, and in advanced heart failure patients with systolic dysfunction that were previously excluded from MYDICAR trials due to pre-existing levels of neutralizing antibodies.
Sign-up for Celladon Corporation Announces New Clinical Development Initiatives for MYDICAR(R) investment picks
SAN DIEGO, July 30, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation, today announced that it will report its results for the second quarter ended June 30, 2014 on Thursday, August 7, 2014.
Sign-up for Celladon to Report Second Quarter 2014 Results on August 7, 2014 investment picks
NETANYA, Israel , July 2, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces 4G Frequencies Tender Published investment picks
NETANYA, Israel , June 17, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces Entering the OTT TV Field investment picks
NETANYA, Israel , July 6, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces Extension Of D&O Indemnification And Exemption investment picks
NETANYA, Israel , June 23, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces Filing of Shelf Prospectus in Israel in Preparation for Debt Offering in Israel investment picks
NETANYA, Israel , July 6, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces Filing Of Supplemental Shelf Offering Report In Israel investment picks
NETANYA, Israel , July 31, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Announces Hearing Regarding 2G and 3G Coverage and Quality Requirements investment picks
NETANYA, Israel , August 19, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom israel Announces Hearing Regarding Call Center Services investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Celestica Completes a Program Share Repurchase to Cellcom israel Announces Hearing Regarding Call Center Services
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices